STRENGTHENING THE PHARMACEUTICAL
INDUSTRY
Overview
India holds a strong position in the global
pharmaceutical industry, it is the largest producer
and supplier of generic drugs. Indian
pharmaceutical Industry supplies about 50% of
global demand for various vaccines.
The industry will be driven by major innovation and
R&D projects, to further strengthen and streamline
the manufacturing and supply chain ecosystem of
the industry. Taking a step closer to India’s
self-reliance agenda, the industry looks forward to
tapping further into the rural space and
encouraging more businesses to enter the pharma
manufacturing space, complemented by stronger
domestic and global demand.
To further strengthen these growth factors,
companies need to focus on creating a
tech-integrated supply chain behind the products,
which is cost-effective, trackable at every point,
collaborative and efficient. The industry requires a
digital structure to meet the procurement needs of
today and tomorrow.
To learn more about our solutions,
write to us at info@moglixbusiness.com.
Procurement & Supply Chain in Pharmaceuticals
Industry
In the face of newfound market forces rallying
corporate bottom lines and top lines, the
pharmaceutical industry continues to face
constraints that restrict the growth of performance
from reaching up to the ceiling. The pharmaceutical
industry is knowledge-intensive and the costs of
research & development costs have a direct
bearing on the costs of new product development.
Pharmaceutical companies need to absorb the
sunk costs of failed trials of drugs and need to
create avenues for loss-offsets in the successful
programs of product launches, thereby rendering
their pricing inefficient and open to competition
from low-cost substitutes.
High development costs in the pharmaceutical
industry pose risks from the cost standpoint.
Late-stage clinical trials that require regulatory
approvals have the effect of prolonging time
durations for roll-out in the market and inhibit the
accrual of economies of scale.
MAJOR CHALLENGES MOGLIX SOLUTIONS

Lack of visibility and transparency into Standardizing and consolidating multiple

procurement operations leads to overstocking vendors by acting as a one-stop-shop for
and sometimes under-stocking of indirect indirect supplies, leading to 10-15% total cost
supplies and delay in processes. savings.

Given the broad customer base across
boundaries, pharmaceutical companies buy
indirect supplies from multiple vendors,
leading to cross-communication, high
procurement costs, and numerous manual
follow-ups.
Non-uniform pricing structures across plants
results in price differentiation for the same
product, leading to higher cost for the same
materials.
Increased rate of rejection or damage in
transit due to quality issues in packaging.
Stock out situations in Inventory due to limited
space and lean stock keeping.
Huge and unconsolidated vendor base makes
GST compliance and product quality an issue.
Establishing a flat pricing structure with ARC led
contracts and standardized discounts across
multiple plants leading to more visibility into the
purchasing process.
Identifying and rectifying the unclear and
ambiguous purchase data and providing clean
data for efficient and accurate procurement
spend analysis.
Providing access to buyers.moglix.com, a private
e-commerce platform for placing and tracking
orders, thus ensuring a fast-running supply chain
with no bottlenecks.
Improving inventory management by enabling
real-time inventory tracking leading to just in
time deliveries and better demand management.
100% GST compliant supply chain with authorized
14,000+ pan India suppliers and 2500+ brands to
choose from.

THE ROAD AHEAD

With the adoption of digital technologies at diverse points of the supply chain from
manufacturing to consumption, pharmaceutical companies can simplify complexities arising
from high inventory holdings, fragmented supplier bases and cost volatilities. It is possible for
pharmaceutical companies to support greater product differentiation and customization and
offer value through more customer-centric services by leveraging real-time information and
unstructured data to proactively respond to accelerating volatility in planning and execution. The
use of advanced analytics can enable pharmaceutical companies to optimize inventory holdings
to maintain a balance between short-term operational planning and tactical level inventory
planning for risk aversion in the intermediate-term.

To learn more about our solutions,

write to us at info@moglixbusiness.com.
 ABOUT THE AUTHORS:

Partha Dash Amandeep Bhan

Senior Vice President Senior Vice President

With 15+ years of experience, Partha Dash brings invaluable Amandeep Singh Bhan is a seasoned business leader with
leadership and insights to Moglix. His expertise lies in 18+ years of experience in functions of sales, strategic
business development, P and L management, international partnerships, and consulting across the globe. His expertise
marketing, emerging market business strategy, sales and lies in strategic planning, business development and
distribution management, retail management and transformation, operational excellence and consultancy.
consumer sales.

Moglix Tech-led MRO Procurement

Reduce direct and indirect costs, consolidate fragmented vendor base, experience consistent buying across multiple sites, and
leverage your data to deliver strategic value through our tech-led procurement and supply chain solutions.

Moglix Packaging Solutions

Choose aesthetic branding display, graphics, and content to enhance your products' overall appearance and ensure lasting
durability and timely delivery through our unified platform for 'concept to delivery' of all packaging products.

Moglix SaaS Solutions

Enhance your contract management journey with the help of an intelligent contract automation solution and spot exceptions,
optimize procurement experience, and improve supply chain performance - all from one intuitive, award-winning solution.

Contact Us: info@moglixbusiness.com

Learn More: https://business.moglix.com/
Stay in Touch: ht ps:/ twit er.com/MoglixBusines ht ps:/ w w.facebo k.com/MoglixBusines ht ps:/ w w.linkedin.com/company/13451 98/admin/ htps:/ w w.yout be.com/chan el/UCKI-TrDW2IJk5X 68I6deMg